Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02599714
Title Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer (PASTOR)
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca

estrogen-receptor positive breast cancer


Fulvestrant + Palbociclib + Vistusertib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.